Clinical Guidelines and Standards Guidelines by Clinical Area
RRM Academy Synopsis
No Treatment Reliably Stops Preterm Labor, ACOG Bulletin Finds
This 2003 ACOG bulletin reviews evidence on treating preterm labor, a top cause of early birth. No drug or bed-rest plan reliably stops labor once it starts, and most women with signs of it still deliver at term.
Key Findings
- Preterm labor comes before 40% to 50% of preterm births. About 467,000 U.S. babies, 11.5% of all births, arrive early each year.
- In 80% of women who show up with signs of preterm labor, birth does not happen early.
- Of 763 women checked for preterm labor symptoms, only 18% gave birth before 37 weeks. Just 3% delivered within 2 weeks of that visit.
- Eight combined randomized trials found antibiotics worked no better than a placebo at delaying birth or lowering newborn breathing problems or infection.
- Bed rest, fluids, and pelvic rest did not appear to lower preterm birth rates. The committee advised against using them routinely.
Interpretation
This 2003 ACOG practice bulletin weighs existing research and grades its strength. A grade of A means good, consistent evidence. A grade of B means the evidence is limited or mixed. The call against routine bed rest is a B-grade finding. The A-grade call is that no drug is a clear first choice: tocolytics may delay birth by days but do not reliably prevent it. Both calls come from weighing many studies together. The findings support continued research into what causes preterm labor in the first place.
RRM Context
This bulletin found that several long-used preterm labor treatments lacked proof of benefit. Bed rest. Hydration. Repeated tocolytic drugs. Each had been common practice for years before its own evidence review found it wanting. Restorative reproductive medicine points to this same gap often: a habit can outlast the data behind it. The bulletin itself notes that what triggers preterm labor is still largely a mystery. ACOG's recommendations manage symptoms, since no known cause points to a treatment.
Abstract not indexed.
Topics
Keywords
Adrenal Cortex Hormones/therapeutic Use, Anti-Bacterial Agents/therapeutic Use, Female, Humans, Incidence, Obstetric Labor, Premature/prevention & Control/therapy, Pregnancy, Tocolytic Agents/therapeutic Use, Adrenal Cortex Hormones, Anti-Bacterial Agents, Tocolytic Agents


